Loading clinical trials...
Loading clinical trials...
The study will only detect hypomanic symptoms in treatment resistant MDD patients by mean of HCL-32 administration. Further re-evaluation of MDD diagnosis is not a direct aim of the study. No efficacy...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AstraZeneca
NCT07592689 · Major Depressive Disorder
NCT07539805 · Major Depressive Disorder (MDD), Probiotic Intervention
NCT07645157 · Major Depressive Disorder (MDD), Probiotic Intervention
NCT07642882 · Fibromyalgia, Depression - Major Depressive Disorder, and more
NCT07076407 · Major Depressive Disorder
Research Site
Agrigento, AG
Research Site
Sciacca, AG
Research Site
Ancona, AN
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions